Rite Aid (NYSE:RAD) is set to post its quarterly earnings results before the market opens on Thursday, December 21st. Analysts expect Rite Aid to post earnings of ($0.02) per share for the quarter.

Rite Aid (NYSE:RAD) last posted its earnings results on Thursday, September 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01). The company had revenue of $7.68 billion during the quarter, compared to the consensus estimate of $7.83 billion. Rite Aid had a net margin of 0.28% and a negative return on equity of 7.51%. The firm’s quarterly revenue was down 4.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.03 earnings per share. On average, analysts expect Rite Aid to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Rite Aid (NYSE RAD) opened at $1.93 on Wednesday. Rite Aid has a 1 year low of $1.38 and a 1 year high of $8.77. The company has a debt-to-equity ratio of 9.71, a current ratio of 1.74 and a quick ratio of 0.77.

A number of research analysts recently issued reports on the stock. Loop Capital restated a “hold” rating and set a $2.00 target price (down from $2.50) on shares of Rite Aid in a research report on Friday, September 29th. Guggenheim restated a “neutral” rating and set a $2.00 target price on shares of Rite Aid in a research report on Monday, October 2nd. Mizuho decreased their target price on shares of Rite Aid from $2.95 to $2.25 and set a “neutral” rating for the company in a research report on Friday, October 6th. Royal Bank of Canada assumed coverage on shares of Rite Aid in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $2.50 target price for the company. Finally, Zacks Investment Research downgraded shares of Rite Aid from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $3.25.

In other Rite Aid news, Director Myrtle S. Potter sold 28,189 shares of the company’s stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $2.09, for a total value of $58,915.01. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.29% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.watchlistnews.com/rite-aid-rad-scheduled-to-post-earnings-on-thursday/1773650.html.

About Rite Aid

Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.

Earnings History for Rite Aid (NYSE:RAD)

Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.